share_log

诺禾致源(688315.SH):专注于开拓前沿分子生物学技术和高性能计算在生命科学研究和人类健康领域的应用

Novo Genesis (688315.SH): Focus on pioneering the application of cutting-edge molecular biology technology and high-performance computing in life science research and human health

Gelonghui Finance ·  May 8 03:51

Gelonghui, May 8 | Novo Zhiyuan (688315.SH) said on an interactive platform that the company focuses on pioneering the application of cutting-edge molecular biology technology and high-performance computing in life science research and human health, and is committed to becoming the world's leading provider of gene technology products and services. Currently, the business covers basic life science research services, medical research and technical services, and database sequencing platform services, providing services such as gene sequencing, mass spectrometry analysis, and bioinformation technology support for global research universities, research institutes, hospitals, pharmaceutical R&D enterprises, agricultural enterprises, etc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment